|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Shire_plc
|
|
gptkbp:acquisitionYear
|
2019
|
|
gptkbp:CEO
|
gptkb:Christophe_Weber
|
|
gptkbp:country
|
gptkb:Japan
|
|
gptkbp:founded
|
1781
|
|
gptkbp:founder
|
gptkb:Chobei_Takeda_I
|
|
gptkbp:globalPresence
|
over 80 countries
|
|
gptkbp:headquarters_location
|
gptkb:Nihonbashi,_Tokyo,_Japan
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:listedOn
|
gptkb:Nikkei_225
gptkb:TOPIX_Core30
|
|
gptkbp:logo
|
Takeda logo.svg
|
|
gptkbp:member
|
gptkb:Japan_Pharmaceutical_Manufacturers_Association
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkb:European_Federation_of_Pharmaceutical_Industries_and_Associations
|
|
gptkbp:notable_drug
|
gptkb:Zanidip
gptkb:Alunbrig
gptkb:Precedex
gptkb:Rozerem
gptkb:Zofran
gptkb:Adcetris
gptkb:Tretten
gptkb:Actos
gptkb:Aloxi
gptkb:Azilva
gptkb:Blopress
gptkb:Colcrys
gptkb:Dexilant
gptkb:Ebrantil
gptkb:Edarbi
gptkb:Edarbyclor
gptkb:Entyvio
gptkb:Firazyr
gptkb:Fosrenol
gptkb:Gammagard
gptkb:Kapidex
gptkb:Lialda
gptkb:Lupron
gptkb:Motegrity
gptkb:Natpara
gptkb:Nesina
gptkb:Ninlaro
gptkb:Oseni
gptkb:Revestive
gptkb:Takhzyro
gptkb:Uloric
gptkb:Velcade
gptkb:Vpriv
gptkb:Vyvanse
gptkb:Xiidra
gptkb:Omontys
Takecab
|
|
gptkbp:numberOfEmployees
|
~49,000
|
|
gptkbp:parentCompany
|
gptkb:Morphic_Therapeutic
gptkb:Crescendo_Biologics
gptkb:CytomX_Therapeutics
gptkb:Alnylam_Pharmaceuticals
gptkb:Evotec
gptkb:Denali_Therapeutics
gptkb:Nimbus_Therapeutics
gptkb:Ovid_Therapeutics
gptkb:Ambys_Medicines
gptkb:Sangamo_Therapeutics
gptkb:Sosei_Heptares
gptkb:ARIAD_Pharmaceuticals
gptkb:Anima_Biotech
gptkb:BioSurplus
gptkb:F-star_Biotechnology
gptkb:GammaDelta_Therapeutics
gptkb:HemoShear_Therapeutics
gptkb:Kymab
gptkb:Millennium_Pharmaceuticals
gptkb:Mimix_Biotherapeutics
gptkb:Nycomed
gptkb:PeptiDream
gptkb:PvP_Biologics
gptkb:Shire_plc
gptkb:Sosei
gptkb:Takeda_Oncology
gptkb:TiGenix
gptkb:Wave_Life_Sciences
gptkb:ImmunoGen
|
|
gptkbp:products
|
vaccines
pharmaceutical drugs
rare disease treatments
gastroenterology medicines
neuroscience medicines
oncology medicines
|
|
gptkbp:revenue
|
3.569 trillion yen (FY2022)
|
|
gptkbp:stockExchange
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:stockSymbol
|
4502
|
|
gptkbp:website
|
https://www.takeda.com/
|
|
gptkbp:bfsParent
|
gptkb:Mortal_Kombat_X
gptkb:Fushimi,_Kyoto,_Japan
gptkb:Sangamo_Therapeutics,_Inc.
gptkb:Sangamo_Therapeutics_(collaboration)
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Takeda
|